Intravitreal Injectable Industry Research Report 2023
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
Highlights
The global Intravitreal Injectable market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravitreal Injectable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravitreal Injectable.
The Intravitreal Injectable market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Intravitreal Injectable market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravitreal Injectable manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Intravitreal Injectable type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Intravitreal Injectable are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Intravitreal Injectable segment by Drug
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Intravitreal Injectable market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Intravitreal Injectable market.
Intravitreal Injectable segment by Disease
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Intravitreal Injectable market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravitreal Injectable market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Intravitreal Injectable and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Intravitreal Injectable industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravitreal Injectable.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Intravitreal Injectable manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Intravitreal Injectable by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Intravitreal Injectable in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by drug, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by disease, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Highlights
The global Intravitreal Injectable market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravitreal Injectable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravitreal Injectable.
The Intravitreal Injectable market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Intravitreal Injectable market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravitreal Injectable manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Regeneron Pharmaceuticals (Eylea)
- Allergan
- EyePoint Pharmaceuticals
- Genentech
- Kanghong Pharmaceutical
Global markets are presented by Intravitreal Injectable type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Intravitreal Injectable are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Intravitreal Injectable segment by Drug
- Anti-VEGF
- Steroids
- Others
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Intravitreal Injectable market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Intravitreal Injectable market.
Intravitreal Injectable segment by Disease
- Macular Degeneration
- Macular Edema
- Uveitis
- Retinal Vein Occlusion
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Intravitreal Injectable market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravitreal Injectable market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Intravitreal Injectable and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Intravitreal Injectable industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravitreal Injectable.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Intravitreal Injectable manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Intravitreal Injectable by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Intravitreal Injectable in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by drug, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by disease, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
- Which product segment grabbed the largest share in the Product Name market?
- How is the competitive scenario of the Product Name market?
- Which are the key factors aiding the Product Name market growth?
- Which are the prominent players in the Product Name market?
- Which region holds the maximum share in the Product Name market?
- What will be the CAGR of the Product Name market during the forecast period?
- Which application segment emerged as the leading segment in the Product Name market?
- What key trends are likely to emerge in the Product Name market in the coming years?
- What will be the Product Name market size by 2028?
- Which company held the largest share in the Product Name market?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Drug (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Disease (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Intravitreal Injectable Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Intravitreal Injectable Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Intravitreal Injectable Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Intravitreal Injectable Revenue of Manufacturers (2018-2023)
Table 9. Global Intravitreal Injectable Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Intravitreal Injectable Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Intravitreal Injectable Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Intravitreal Injectable, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravitreal Injectable by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Regeneron Pharmaceuticals (Eylea) Company Information
Table 17. Regeneron Pharmaceuticals (Eylea) Business Overview
Table 18. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolio
Table 20. Regeneron Pharmaceuticals (Eylea) Recent Developments
Table 21. Allergan Company Information
Table 22. Allergan Business Overview
Table 23. Allergan Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Allergan Intravitreal Injectable Product Portfolio
Table 25. Allergan Recent Developments
Table 26. EyePoint Pharmaceuticals Company Information
Table 27. EyePoint Pharmaceuticals Business Overview
Table 28. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolio
Table 30. EyePoint Pharmaceuticals Recent Developments
Table 31. Genentech Company Information
Table 32. Genentech Business Overview
Table 33. Genentech Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Genentech Intravitreal Injectable Product Portfolio
Table 35. Genentech Recent Developments
Table 36. Kanghong Pharmaceutical Company Information
Table 37. Kanghong Pharmaceutical Business Overview
Table 38. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Kanghong Pharmaceutical Intravitreal Injectable Product Portfolio
Table 40. Kanghong Pharmaceutical Recent Developments
Table 41. Global Intravitreal Injectable Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Global Intravitreal Injectable Sales by Region (2018-2023) & (K Units)
Table 43. Global Intravitreal Injectable Sales Market Share by Region (2018-2023)
Table 44. Global Intravitreal Injectable Sales by Region (2024-2029) & (K Units)
Table 45. Global Intravitreal Injectable Sales Market Share by Region (2024-2029)
Table 46. Global Intravitreal Injectable Revenue by Region (2018-2023) & (US$ Million)
Table 47. Global Intravitreal Injectable Revenue Market Share by Region (2018-2023)
Table 48. Global Intravitreal Injectable Revenue by Region (2024-2029) & (US$ Million)
Table 49. Global Intravitreal Injectable Revenue Market Share by Region (2024-2029)
Table 50. North America Intravitreal Injectable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 51. North America Intravitreal Injectable Sales by Country (2018-2023) & (K Units)
Table 52. North America Intravitreal Injectable Sales by Country (2024-2029) & (K Units)
Table 53. North America Intravitreal Injectable Revenue by Country (2018-2023) & (US$ Million)
Table 54. North America Intravitreal Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 55. Europe Intravitreal Injectable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. Europe Intravitreal Injectable Sales by Country (2018-2023) & (K Units)
Table 57. Europe Intravitreal Injectable Sales by Country (2024-2029) & (K Units)
Table 58. Europe Intravitreal Injectable Revenue by Country (2018-2023) & (US$ Million)
Table 59. Europe Intravitreal Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 60. Asia Pacific Intravitreal Injectable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. Asia Pacific Intravitreal Injectable Sales by Country (2018-2023) & (K Units)
Table 62. Asia Pacific Intravitreal Injectable Sales by Country (2024-2029) & (K Units)
Table 63. Asia Pacific Intravitreal Injectable Revenue by Country (2018-2023) & (US$ Million)
Table 64. Asia Pacific Intravitreal Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 65. Latin America Intravitreal Injectable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Latin America Intravitreal Injectable Sales by Country (2018-2023) & (K Units)
Table 67. Latin America Intravitreal Injectable Sales by Country (2024-2029) & (K Units)
Table 68. Latin America Intravitreal Injectable Revenue by Country (2018-2023) & (US$ Million)
Table 69. Latin America Intravitreal Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 70. Middle East and Africa Intravitreal Injectable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Middle East and Africa Intravitreal Injectable Sales by Country (2018-2023) & (K Units)
Table 72. Middle East and Africa Intravitreal Injectable Sales by Country (2024-2029) & (K Units)
Table 73. Middle East and Africa Intravitreal Injectable Revenue by Country (2018-2023) & (US$ Million)
Table 74. Middle East and Africa Intravitreal Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 75. Global Intravitreal Injectable Sales by Drug (2018-2023) & (K Units)
Table 76. Global Intravitreal Injectable Sales by Drug (2024-2029) & (K Units)
Table 77. Global Intravitreal Injectable Sales Market Share by Drug (2018-2023)
Table 78. Global Intravitreal Injectable Sales Market Share by Drug (2024-2029)
Table 79. Global Intravitreal Injectable Revenue by Drug (2018-2023) & (US$ Million)
Table 80. Global Intravitreal Injectable Revenue by Drug (2024-2029) & (US$ Million)
Table 81. Global Intravitreal Injectable Revenue Market Share by Drug (2018-2023)
Table 82. Global Intravitreal Injectable Revenue Market Share by Drug (2024-2029)
Table 83. Global Intravitreal Injectable Price by Drug (2018-2023) & (US$/Unit)
Table 84. Global Intravitreal Injectable Price by Drug (2024-2029) & (US$/Unit)
Table 85. Global Intravitreal Injectable Sales by Disease (2018-2023) & (K Units)
Table 86. Global Intravitreal Injectable Sales by Disease (2024-2029) & (K Units)
Table 87. Global Intravitreal Injectable Sales Market Share by Disease (2018-2023)
Table 88. Global Intravitreal Injectable Sales Market Share by Disease (2024-2029)
Table 89. Global Intravitreal Injectable Revenue by Disease (2018-2023) & (US$ Million)
Table 90. Global Intravitreal Injectable Revenue by Disease (2024-2029) & (US$ Million)
Table 91. Global Intravitreal Injectable Revenue Market Share by Disease (2018-2023)
Table 92. Global Intravitreal Injectable Revenue Market Share by Disease (2024-2029)
Table 93. Global Intravitreal Injectable Price by Disease (2018-2023) & (US$/Unit)
Table 94. Global Intravitreal Injectable Price by Disease (2024-2029) & (US$/Unit)
Table 95. Key Raw Materials
Table 96. Raw Materials Key Suppliers
Table 97. Intravitreal Injectable Distributors List
Table 98. Intravitreal Injectable Customers List
Table 99. Intravitreal Injectable Industry Trends
Table 100. Intravitreal Injectable Industry Drivers
Table 101. Intravitreal Injectable Industry Restraints
Table 102. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Drug (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Disease (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Intravitreal Injectable Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Intravitreal Injectable Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Intravitreal Injectable Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Intravitreal Injectable Revenue of Manufacturers (2018-2023)
Table 9. Global Intravitreal Injectable Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Intravitreal Injectable Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Intravitreal Injectable Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Intravitreal Injectable, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravitreal Injectable by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Regeneron Pharmaceuticals (Eylea) Company Information
Table 17. Regeneron Pharmaceuticals (Eylea) Business Overview
Table 18. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolio
Table 20. Regeneron Pharmaceuticals (Eylea) Recent Developments
Table 21. Allergan Company Information
Table 22. Allergan Business Overview
Table 23. Allergan Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Allergan Intravitreal Injectable Product Portfolio
Table 25. Allergan Recent Developments
Table 26. EyePoint Pharmaceuticals Company Information
Table 27. EyePoint Pharmaceuticals Business Overview
Table 28. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolio
Table 30. EyePoint Pharmaceuticals Recent Developments
Table 31. Genentech Company Information
Table 32. Genentech Business Overview
Table 33. Genentech Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Genentech Intravitreal Injectable Product Portfolio
Table 35. Genentech Recent Developments
Table 36. Kanghong Pharmaceutical Company Information
Table 37. Kanghong Pharmaceutical Business Overview
Table 38. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Kanghong Pharmaceutical Intravitreal Injectable Product Portfolio
Table 40. Kanghong Pharmaceutical Recent Developments
Table 41. Global Intravitreal Injectable Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Global Intravitreal Injectable Sales by Region (2018-2023) & (K Units)
Table 43. Global Intravitreal Injectable Sales Market Share by Region (2018-2023)
Table 44. Global Intravitreal Injectable Sales by Region (2024-2029) & (K Units)
Table 45. Global Intravitreal Injectable Sales Market Share by Region (2024-2029)
Table 46. Global Intravitreal Injectable Revenue by Region (2018-2023) & (US$ Million)
Table 47. Global Intravitreal Injectable Revenue Market Share by Region (2018-2023)
Table 48. Global Intravitreal Injectable Revenue by Region (2024-2029) & (US$ Million)
Table 49. Global Intravitreal Injectable Revenue Market Share by Region (2024-2029)
Table 50. North America Intravitreal Injectable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 51. North America Intravitreal Injectable Sales by Country (2018-2023) & (K Units)
Table 52. North America Intravitreal Injectable Sales by Country (2024-2029) & (K Units)
Table 53. North America Intravitreal Injectable Revenue by Country (2018-2023) & (US$ Million)
Table 54. North America Intravitreal Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 55. Europe Intravitreal Injectable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. Europe Intravitreal Injectable Sales by Country (2018-2023) & (K Units)
Table 57. Europe Intravitreal Injectable Sales by Country (2024-2029) & (K Units)
Table 58. Europe Intravitreal Injectable Revenue by Country (2018-2023) & (US$ Million)
Table 59. Europe Intravitreal Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 60. Asia Pacific Intravitreal Injectable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. Asia Pacific Intravitreal Injectable Sales by Country (2018-2023) & (K Units)
Table 62. Asia Pacific Intravitreal Injectable Sales by Country (2024-2029) & (K Units)
Table 63. Asia Pacific Intravitreal Injectable Revenue by Country (2018-2023) & (US$ Million)
Table 64. Asia Pacific Intravitreal Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 65. Latin America Intravitreal Injectable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Latin America Intravitreal Injectable Sales by Country (2018-2023) & (K Units)
Table 67. Latin America Intravitreal Injectable Sales by Country (2024-2029) & (K Units)
Table 68. Latin America Intravitreal Injectable Revenue by Country (2018-2023) & (US$ Million)
Table 69. Latin America Intravitreal Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 70. Middle East and Africa Intravitreal Injectable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Middle East and Africa Intravitreal Injectable Sales by Country (2018-2023) & (K Units)
Table 72. Middle East and Africa Intravitreal Injectable Sales by Country (2024-2029) & (K Units)
Table 73. Middle East and Africa Intravitreal Injectable Revenue by Country (2018-2023) & (US$ Million)
Table 74. Middle East and Africa Intravitreal Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 75. Global Intravitreal Injectable Sales by Drug (2018-2023) & (K Units)
Table 76. Global Intravitreal Injectable Sales by Drug (2024-2029) & (K Units)
Table 77. Global Intravitreal Injectable Sales Market Share by Drug (2018-2023)
Table 78. Global Intravitreal Injectable Sales Market Share by Drug (2024-2029)
Table 79. Global Intravitreal Injectable Revenue by Drug (2018-2023) & (US$ Million)
Table 80. Global Intravitreal Injectable Revenue by Drug (2024-2029) & (US$ Million)
Table 81. Global Intravitreal Injectable Revenue Market Share by Drug (2018-2023)
Table 82. Global Intravitreal Injectable Revenue Market Share by Drug (2024-2029)
Table 83. Global Intravitreal Injectable Price by Drug (2018-2023) & (US$/Unit)
Table 84. Global Intravitreal Injectable Price by Drug (2024-2029) & (US$/Unit)
Table 85. Global Intravitreal Injectable Sales by Disease (2018-2023) & (K Units)
Table 86. Global Intravitreal Injectable Sales by Disease (2024-2029) & (K Units)
Table 87. Global Intravitreal Injectable Sales Market Share by Disease (2018-2023)
Table 88. Global Intravitreal Injectable Sales Market Share by Disease (2024-2029)
Table 89. Global Intravitreal Injectable Revenue by Disease (2018-2023) & (US$ Million)
Table 90. Global Intravitreal Injectable Revenue by Disease (2024-2029) & (US$ Million)
Table 91. Global Intravitreal Injectable Revenue Market Share by Disease (2018-2023)
Table 92. Global Intravitreal Injectable Revenue Market Share by Disease (2024-2029)
Table 93. Global Intravitreal Injectable Price by Disease (2018-2023) & (US$/Unit)
Table 94. Global Intravitreal Injectable Price by Disease (2024-2029) & (US$/Unit)
Table 95. Key Raw Materials
Table 96. Raw Materials Key Suppliers
Table 97. Intravitreal Injectable Distributors List
Table 98. Intravitreal Injectable Customers List
Table 99. Intravitreal Injectable Industry Trends
Table 100. Intravitreal Injectable Industry Drivers
Table 101. Intravitreal Injectable Industry Restraints
Table 102. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Intravitreal InjectableProduct Picture
Figure 5. Global Intravitreal Injectable Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Intravitreal Injectable Market Size (2018-2029) & (US$ Million)
Figure 7. Global Intravitreal Injectable Sales (2018-2029) & (K Units)
Figure 8. Global Intravitreal Injectable Average Price (US$/Unit) & (2018-2029)
Figure 9. Anti-VEGF Product Picture
Figure 10. Steroids Product Picture
Figure 11. Others Product Picture
Figure 12. Macular Degeneration Product Picture
Figure 13. Macular Edema Product Picture
Figure 14. Uveitis Product Picture
Figure 15. Retinal Vein Occlusion Product Picture
Figure 16. Others Product Picture
Figure 17. Global Intravitreal Injectable Revenue Share by Manufacturers in 2022
Figure 18. Global Manufacturers of Intravitreal Injectable, Manufacturing Sites & Headquarters
Figure 19. Global Manufacturers of Intravitreal Injectable, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Intravitreal Injectable Players Market Share by Revenue in 2022
Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. Global Intravitreal Injectable Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. Global Intravitreal Injectable Sales by Region in 2022
Figure 24. Global Intravitreal Injectable Revenue by Region in 2022
Figure 25. North America Intravitreal Injectable Market Size by Country in 2022
Figure 26. North America Intravitreal Injectable Sales Market Share by Country (2018-2029)
Figure 27. North America Intravitreal Injectable Revenue Market Share by Country (2018-2029)
Figure 28. United States Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Intravitreal Injectable Market Size by Country in 2022
Figure 31. Europe Intravitreal Injectable Sales Market Share by Country (2018-2029)
Figure 32. Europe Intravitreal Injectable Revenue Market Share by Country (2018-2029)
Figure 33. Germany Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Intravitreal Injectable Market Size by Country in 2022
Figure 39. Asia Pacific Intravitreal Injectable Sales Market Share by Country (2018-2029)
Figure 40. Asia Pacific Intravitreal Injectable Revenue Market Share by Country (2018-2029)
Figure 41. China Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. South Korea Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. India Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Australia Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. China Taiwan Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Indonesia Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Thailand Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Malaysia Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Latin America Intravitreal Injectable Market Size by Country in 2022
Figure 51. Latin America Intravitreal Injectable Sales Market Share by Country (2018-2029)
Figure 52. Latin America Intravitreal Injectable Revenue Market Share by Country (2018-2029)
Figure 53. Mexico Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Brazil Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Argentina Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Middle East and Africa Intravitreal Injectable Market Size by Country in 2022
Figure 57. Middle East and Africa Intravitreal Injectable Sales Market Share by Country (2018-2029)
Figure 58. Middle East and Africa Intravitreal Injectable Revenue Market Share by Country (2018-2029)
Figure 59. Turkey Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Saudi Arabia Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. UAE Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 62. Global Intravitreal Injectable Sales Market Share by Drug (2018-2029)
Figure 63. Global Intravitreal Injectable Revenue Market Share by Drug (2018-2029)
Figure 64. Global Intravitreal Injectable Price (US$/Unit) by Drug (2018-2029)
Figure 65. Global Intravitreal Injectable Sales Market Share by Disease (2018-2029)
Figure 66. Global Intravitreal Injectable Revenue Market Share by Disease (2018-2029)
Figure 67. Global Intravitreal Injectable Price (US$/Unit) by Disease (2018-2029)
Figure 68. Intravitreal Injectable Value Chain
Figure 69. Intravitreal Injectable Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Intravitreal Injectable Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Intravitreal InjectableProduct Picture
Figure 5. Global Intravitreal Injectable Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Intravitreal Injectable Market Size (2018-2029) & (US$ Million)
Figure 7. Global Intravitreal Injectable Sales (2018-2029) & (K Units)
Figure 8. Global Intravitreal Injectable Average Price (US$/Unit) & (2018-2029)
Figure 9. Anti-VEGF Product Picture
Figure 10. Steroids Product Picture
Figure 11. Others Product Picture
Figure 12. Macular Degeneration Product Picture
Figure 13. Macular Edema Product Picture
Figure 14. Uveitis Product Picture
Figure 15. Retinal Vein Occlusion Product Picture
Figure 16. Others Product Picture
Figure 17. Global Intravitreal Injectable Revenue Share by Manufacturers in 2022
Figure 18. Global Manufacturers of Intravitreal Injectable, Manufacturing Sites & Headquarters
Figure 19. Global Manufacturers of Intravitreal Injectable, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Intravitreal Injectable Players Market Share by Revenue in 2022
Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. Global Intravitreal Injectable Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. Global Intravitreal Injectable Sales by Region in 2022
Figure 24. Global Intravitreal Injectable Revenue by Region in 2022
Figure 25. North America Intravitreal Injectable Market Size by Country in 2022
Figure 26. North America Intravitreal Injectable Sales Market Share by Country (2018-2029)
Figure 27. North America Intravitreal Injectable Revenue Market Share by Country (2018-2029)
Figure 28. United States Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Intravitreal Injectable Market Size by Country in 2022
Figure 31. Europe Intravitreal Injectable Sales Market Share by Country (2018-2029)
Figure 32. Europe Intravitreal Injectable Revenue Market Share by Country (2018-2029)
Figure 33. Germany Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Intravitreal Injectable Market Size by Country in 2022
Figure 39. Asia Pacific Intravitreal Injectable Sales Market Share by Country (2018-2029)
Figure 40. Asia Pacific Intravitreal Injectable Revenue Market Share by Country (2018-2029)
Figure 41. China Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. South Korea Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. India Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Australia Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. China Taiwan Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Indonesia Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Thailand Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Malaysia Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Latin America Intravitreal Injectable Market Size by Country in 2022
Figure 51. Latin America Intravitreal Injectable Sales Market Share by Country (2018-2029)
Figure 52. Latin America Intravitreal Injectable Revenue Market Share by Country (2018-2029)
Figure 53. Mexico Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Brazil Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Argentina Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Middle East and Africa Intravitreal Injectable Market Size by Country in 2022
Figure 57. Middle East and Africa Intravitreal Injectable Sales Market Share by Country (2018-2029)
Figure 58. Middle East and Africa Intravitreal Injectable Revenue Market Share by Country (2018-2029)
Figure 59. Turkey Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Saudi Arabia Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. UAE Intravitreal Injectable Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 62. Global Intravitreal Injectable Sales Market Share by Drug (2018-2029)
Figure 63. Global Intravitreal Injectable Revenue Market Share by Drug (2018-2029)
Figure 64. Global Intravitreal Injectable Price (US$/Unit) by Drug (2018-2029)
Figure 65. Global Intravitreal Injectable Sales Market Share by Disease (2018-2029)
Figure 66. Global Intravitreal Injectable Revenue Market Share by Disease (2018-2029)
Figure 67. Global Intravitreal Injectable Price (US$/Unit) by Disease (2018-2029)
Figure 68. Intravitreal Injectable Value Chain
Figure 69. Intravitreal Injectable Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Intravitreal Injectable Industry Opportunities and Challenges
